Elizabeth Gebarski
Professional Bio
Elizabeth Gebarski focuses her practice in the areas of hospital and health law. Her practice includes advising clients on regulatory and compliance issues, business development, and licensing issues. She is well-versed in providing 340B Drug Pricing Program regulatory, compliance, audit, and contract support to covered entities, contract pharmacies, and other key stakeholders.
PhRMA 2-0 in The Orphan Drug Wars
To Be or Not to 340B Blog ·
Breaking Down the Proposed Omnibus Guidance – Child Sites
To Be or Not to 340B Blog ·
Breaking Down the Proposed Omnibus Guidance – Covered Entity Eligibility, Registration & Termination
To Be or Not to 340B Blog ·
The Proposed 340B Drug Pricing Program Omnibus Guidelines Have Landed
To Be or Not to 340B Blog ·
Finally! HRSA Proposes Manufacturer Civil Monetary Penalties
To Be or Not to 340B Blog ·